Esonarimod is primarily utilized in the field of medicine, particularly for its immunomodulatory properties. It is being investigated for its potential in treating autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, by modulating the immune response to reduce inflammation and prevent tissue damage. Additionally, esonarimod has shown promise in clinical trials for its ability to target specific pathways involved in autoimmune disorders, offering a more targeted approach compared to traditional therapies. Its application extends to research settings where it is used to study immune system regulation and develop novel treatments for chronic inflammatory conditions.